Hemorrhagic complications with prasugrel therapy for vascular neurointerventional procedures.
Department of Interventional Neuroradiology/Endovascular Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA. tleslie-mazwi@mgh.harvard.edu
Thabele M
TM
Leslie-Mazwi
Ronil V
RV
Chandra
Albert J
AJ
Yoo
James D
JD
Rabinov
Joshua A
JA
Hirsch
D002543:Cerebral Hemorrhage / Q000000981:diagnostic imaging* / Q000209:etiology*; D004621:Embolization, Therapeutic / Q000009:adverse effects*; D057510:Endovascular Procedures / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D018696:Neuroprotective Agents / Q000008:administration & dosage*; D010879:Piperazines / Q000008:administration & dosage* / Q000009:adverse effects*; D000068799:Prasugrel Hydrochloride; D058920:Purinergic P2X Receptor Antagonists / Q000009:adverse effects*; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage*; D011859:Radiography; D013876:Thiophenes / Q000008:administration & dosage* / Q000009:adverse effects*
D018696:Neuroprotective Agents; D010879:Piperazines; D058920:Purinergic P2X Receptor Antagonists; D058921:Purinergic P2Y Receptor Antagonists; D013876:Thiophenes; D000068799:Prasugrel Hydrochloride